Scientists want to know who will benefit most, what the long-term effects might be and whether the treatments will change views on obesity.
It’s rare to find a product so successful that its makers stop advertising it. But that’s what happened to the weight-loss drug Wegovy in May. In the United States, where prescription drugs can be advertised, developer Novo Nordisk pulled its television adverts because it couldn’t keep up with demand.
Read more: https://www.nature.com/articles/d41586-023-02445-4
